NCT02055222View on ClinicalTrials.gov

Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease

CompletedOBSERVATIONAL
Enrollment

7

Participants

Timeline

Start Date

October 14, 2014

Primary Completion Date

January 1, 2018

Study Completion Date

August 23, 2018

Conditions
Pulmonary FibrosisLung Disease
Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT02055222 - Clinical Outcomes and Molecular Phenotypes in Smokers With Parenchymal Lung Disease | Biotech Hunter | Biotech Hunter